Effect of pentoxifylline in reducing proteinuria in patients with type 2 of diabetes
Phase 2
- Conditions
- Diabete.Diabetic nephropathy
- Registration Number
- IRCT2016111827097N2
- Lead Sponsor
- Ardebil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
patients with type 2 of diabetes; proteinuria greater than 500 mg per 24 hours; people who are treated with ACEI and ARB; patients who do not have contra-indications of PTX. Exclusion criteria: proteinuria less than 500 mg per 24 hours; people who had a history of retinal hemorrhages; who had a history of MI; patients who have contra-indications of PTX; those treated with ACEI and ARB not; people who have hypotension
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proteinuria. Timepoint: befor and after the study. Method of measurement: mg/d.
- Secondary Outcome Measures
Name Time Method rea. Timepoint: befor and after the study. Method of measurement: mg/dl.